Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

National Institute of Allergy and Infectious Diseases
Mini-Summit on Adenovirus Platforms for HIV Vaccines

Thursday, September 19, 2013


The Mini-Summit brought together experts in all aspects of HIV vaccinology,  including those working with non-human primate models, virologists, clinical  trialists, immunologists, epidemiologists, and statisticians. The goal was to  determine the best way forward for evaluating Ad-HIV vectors based on an  in-depth discussion about HIV vaccine platforms using recombinant Ad vectors.


The Mini-Summit included a focused discussion on questions pertaining to the impact of Ad5 vaccines on HIV acquisition, potential mechanisms involved, and how this informs future human clinical trials.

Agenda (PDF)


An archived webcast is available.

Last Updated September 26, 2013

Last Reviewed September 04, 2013